Oppenheimer Asset Management Inc. Atri Cure, Inc. Transaction History

Oppenheimer Asset Management Inc.

$6.65 Billion
Q1 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 10,462 shares of ATRC stock, worth $234,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,462

Previous 8,900 17.55%

Holding current value

$234,244

Previous $317,000 0.32%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$28.21 - $37.78 $44,064 - $59,012	1,562 Added 17.55%	10,462 $318,000
Q4 2023 Feb 13, 2024	SELL	$32.99 - $43.25 $18,804 - $24,652	-570 Reduced 6.02%	8,900 $317,000
Q3 2023 Nov 07, 2023	SELL	$41.12 - $57.73 $2,796 - $3,925	-68 Reduced 0.71%	9,470 $414,000
Q2 2023 Aug 02, 2023	SELL	$40.44 - $49.6 $9,139 - $11,209	-226 Reduced 2.31%	9,538 $470,000
Q1 2023 May 10, 2023	BUY	$35.87 - $47.22 $18,437 - $24,271	514 Added 5.56%	9,764 $404,000

Q4 2022 Feb 06, 2023	SELL	$33.48 - $47.45 $63,310 - $89,727	-1,891 Reduced 16.97%	9,250 $410,000
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $2,486 - $3,420	-65 Reduced 0.58%	11,141 $436,000
Q2 2022 Aug 08, 2022	SELL	$35.1 - $66.01 $12,144 - $22,839	-346 Reduced 3.0%	11,206 $458,000
Q1 2022 May 12, 2022	SELL	$57.43 - $71.39 $4,824 - $5,996	-84 Reduced 0.72%	11,552 $759,000
Q4 2021 Feb 02, 2022	SELL	$63.4 - $87.14 $22,380 - $30,760	-353 Reduced 2.94%	11,636 $809,000
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $32,353 - $39,442	-467 Reduced 3.75%	11,989 $834,000
Q2 2021 Aug 03, 2021	SELL	$64.13 - $80.18 $19,559 - $24,454	-305 Reduced 2.39%	12,456 $988,000
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $8,713 - $10,850	-162 Reduced 1.25%	12,761 $836,000
Q4 2020 Feb 11, 2021	BUY	$34.56 - $57.55 $145,843 - $242,861	4,220 Added 48.49%	12,923 $719,000
Q3 2020 Nov 13, 2020	SELL	$38.36 - $46.91 $3,912 - $4,784	-102 Reduced 1.16%	8,703 $347,000
Q2 2020 Aug 11, 2020	BUY	$31.78 - $51.19 $217,788 - $350,805	6,853 Added 351.08%	8,805 $396,000
Q1 2020 May 08, 2020	SELL	$24.49 - $43.84 $3,404 - $6,093	-139 Reduced 6.65%	1,952 $66,000
Q4 2019 Feb 07, 2020	BUY	$24.06 - $32.51 $12,078 - $16,320	502 Added 31.59%	2,091 $68,000
Q3 2019 Oct 31, 2019	SELL	$23.81 - $32.52 $190 - $260	-8 Reduced 0.5%	1,589 $40,000
Q2 2019 Aug 09, 2019	BUY	$26.85 - $30.74 $22,903 - $26,221	853 Added 114.65%	1,597 $48,000
Q1 2019 Apr 24, 2019	BUY	$26.38 - $33.34 $1,028 - $1,300	39 Added 5.53%	744 $20,000
Q4 2018 Jan 30, 2019	BUY	$26.66 - $34.85 $18,795 - $24,569	705 New	705 $22,000

Others Institutions Holding ATRC

# of Institutions

239

Shares Held

46.7M

Call Options Held

95.7K

Put Options Held

119K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.04B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Atri Cure, Inc. Transaction History